These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17933434)

  • 1. [Typhlitis: report of a case and review of the literature].
    Robaday S; Kerleau JM; Tapon E; Levesque H; Marie I
    Rev Med Interne; 2008 Mar; 29(3):224-7. PubMed ID: 17933434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typhlitis as a complication of alemtuzumab therapy.
    Marie I; Robaday S; Kerleau JM; Jardin F; Levesque H
    Haematologica; 2007 May; 92(5):e62-3. PubMed ID: 17562596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutropenic enterocolitis.
    Rodrigues FG; Dasilva G; Wexner SD
    World J Gastroenterol; 2017 Jan; 23(1):42-47. PubMed ID: 28104979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.
    Laurenti L; Piccioni P; Cattani P; Cingolani A; Efremov D; Chiusolo P; Tarnani M; Fadda G; Sica S; Leone G
    Haematologica; 2004 Oct; 89(10):1248-52. PubMed ID: 15477211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?
    Smolej L
    Blood; 2008 Sep; 112(5):2167. PubMed ID: 18725576
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutropenic enterocolitis.
    Cloutier RL
    Emerg Med Clin North Am; 2009 Aug; 27(3):415-22. PubMed ID: 19646645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia complicated by neutropenic enterocolitis.
    Tinsa F; Necib N; Guesmi M; Bousnina O; Douira W; Bousetta K; Bousnina S
    Tunis Med; 2008 Nov; 86(11):1011-3. PubMed ID: 19213496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typhlitis with concurrent appendicitis in a patient with chronic lymphocytic leukemia.
    Cogle CR; Minter RM; Meyers CL; Rout WR; Wingard JR
    Clin Adv Hematol Oncol; 2003 May; 1(5):284-6; discussion 286. PubMed ID: 16224422
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and Management of Typhlitis and Neutropenic Enterocolitis in Children with Cancer.
    Cross SJ; Patel JR; Wolf J
    Pediatr Infect Dis J; 2022 Aug; 41(8):e326-e328. PubMed ID: 35421049
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab.
    O'Brien SM; Keating MJ; Mocarski ES
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):125-30. PubMed ID: 17026823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
    Montillo M; Tedeschi A; Miqueleiz S; Veronese S; Cairoli R; Intropido L; Ricci F; Colosimo A; Scarpati B; Montagna M; Nichelatti M; Regazzi M; Morra E
    J Clin Oncol; 2006 May; 24(15):2337-42. PubMed ID: 16618945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of neutropenic enterocolitis in children with cancer.
    Sundell N; Boström H; Edenholm M; Abrahamsson J
    Acta Paediatr; 2012 Mar; 101(3):308-12. PubMed ID: 21910749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful oral valganciclovir treatment of cytomegalovirus infection during Campath-1H therapy.
    González H; Vernant JP; Caumes E
    Leukemia; 2005 Mar; 19(3):478. PubMed ID: 15618954
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis due to Mycobacterium bovis after alemtuzumab administration.
    Abad S; Gyan E; Moachon L; Bouscary D; Sicard D; Dreyfus F; Blanche P
    Clin Infect Dis; 2003 Jul; 37(2):e27-8. PubMed ID: 12856232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valganciclovir as CMV reactivation prophylaxis in patients receiving alemtuzumab for marrow failure syndromes.
    Risitano AM; Serio B; Selleri C; Rotoli B
    Ann Hematol; 2009 Dec; 88(12):1261-2. PubMed ID: 19430789
    [No Abstract]   [Full Text] [Related]  

  • 16. [What is your diagnosis? Neutropenic colitis (neutropenic typhlitis)].
    Ernst S; Bühlmann M; Stucki A; Bükki J; Stanga Z
    Praxis (Bern 1994); 2007 Jan; 96(4):99-100. PubMed ID: 17294584
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for typhlitis in pediatric patients with cancer.
    Moran H; Yaniv I; Ashkenazi S; Schwartz M; Fisher S; Levy I
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):630-4. PubMed ID: 19644402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
    Ng AP; Worth L; Chen L; Seymour JF; Prince HM; Slavin M; Thursky K
    Haematologica; 2005 Dec; 90(12):1672-9. PubMed ID: 16330442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenic enterocolitis in lung cancer: a report of two cases and a review of the literature.
    Furonaka M; Miyazaki M; Nakajima M; Hirata S; Fujitaka K; Kondo K; Yokoyama A; Maeda H; Kohno N
    Intern Med; 2005 May; 44(5):467-70. PubMed ID: 15942096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
    Zinzani PL; Alinari L; Tani M; Fina M; Pileri S; Baccarani M
    Haematologica; 2005 May; 90(5):702-3. PubMed ID: 15921394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.